CD4 and AIDS: These results together suggest that the effect of clinical outcome at pre-cART on T-cell responses to epitopes under cART is minimal; however, they imply that there is a negative correlation between CD4 count at pre-cART and the frequency of positive T-cell responses under cART in individuals with a worse clinical outcome, such as AIDS patients.